Navigation Links
Barbra Streisand endows program at Cedars-Sinai women's heart center
Date:4/16/2008

LOS ANGELES (April 16, 2008) A bold new resource for womens heart health, The Barbra Streisand Womens Cardiovascular Research and Education Program at Cedars-Sinai, has been created with a philanthropic gift of $5 million. The gift brings to nearly $16 million the money raised from her recent concert tours she has directed to charitable distribution in the areas of education, the environment, womens health, and other key civic concerns.

Cardiovascular disease is the leading killer of women, says Eduardo Marbn, MD, PhD, director at the Cedars-Sinai Heart Institute. It kills nearly 500,000 women in the U.S. each year, more than all cancers combined. The medical system has failed to recognize female-pattern heart attack symptoms; current testing and treatments are geared toward male physiology.

Ms. Streisand, who has contributed to womens health programs through the Streisand Foundation since 1986, explained: Women need to be educated about female cardiovascular disease, and the medical community must be propelled toward change. Just like with breast cancer, the impetus must come from women themselves striving to become empowered to reduce their risks for heart disease.

Streisands endowment will provide permanent funding for research and education at the Cedars-Sinai Womens Heart Center, which will empower women with vital information about female cardiovascular disease and raise awareness of the disease within the medical community. It will expand current and future research efforts and create breakthrough diagnostics, treatments and technologies. It will facilitate better understanding of gender differences in heart disease, with the aim of improving treatment options for women at risk for, or suffering from heart disease.

The endowment supports the work of C. Noel Bairey Merz, MD, director of the Womens Heart Center at Cedars-Sinai and holder of the Womens Guild Chair in Womens Health and is organized around the five frontiers of womens cardiovascular research:

  • Ending cardiac death in women through early detection

  • Advancing new treatments for microvascular coronary dysfunction, an often deadly disorder primarily affecting women

  • Identifying gender-specific genes and proteins that increase or reduce the risk of heart disease in women

  • Conducting clinical trials of promising new drugs for women

  • Understanding how to harness nutrition, exercise, and stress management to reduce heart disease in women

Even physicians do not fully appreciate the degree to which women are at risk for heart disease. Most are insufficiently aware that a woman having a heart attack is 20 percent more likely to die from it than a man. Dr. Bairey Merz urges that It must become a top priority on the national medical agenda to make testing, diagnosis and treatments more relevant to female physiology. We are thrilled Ms. Streisand has chosen to make womens heart health a priority of her philanthropic giving. She goes on to explain: As an endowment, funding for the dissemination of education -- both among women and within the medical community -- and research into relevant testing and treatments can continue, not just for the immediate future, but for generations to come.


'/>"/>

Contact: Janet Keller
janet.keller@cshs.org
310-423-6635
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. John Hancocks EZ Route Post-Enrollment Education Program Wins 2008 Insight Award for Customer Advocacy in Financial Services
2. Nations Vending Industry Unveils New Health Oriented Vending Program:
3. Video: National Association of School Nurses Launches Educational Program to Address Surge of Prescription Drug Abuse by Americas Youth
4. Brandes Proposes 130 yen per Share Dividend and 10 Million Share Buyback Program for Ono Pharmaceutical Annual Meeting
5. Draft National Toxicology Program Report Supports Safety of Bisphenol A
6. Palmetto GBA Ranked Among Nations Best for Ethics, Compliance Programs
7. Precyse Solutions Launches Clinical Documentation Improvement Program to Assist Hospitals in Accelerating Revenues
8. Intronis Technologies eSureIT Partner Program Certified Gold By CMP Channels VARBusiness
9. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
10. McCarty Cancer Foundation Awards $50,000 Grant for Myeloma Research Program at Karmanos Cancer Institute
11. New Montefiore Program Targets Elder Abuse and Neglect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... agency serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing ... fighting to overcome a rare and deadly chromosome abnormality. , After struggling since ...
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: